17
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T78573 | Glucocerebrosidase | GCase,Glucosylceramidase | Endogenous Metabolite |
Glucocerebrosidase (Glucosylceramidase; GBA), a lysosomal enzyme, catalyzes the hydrolysis of the β-glucosidic linkage in glucocerebroside (GC) to yield glucose and ceramide [1]. | |||
T60353 | Glucocerebrosidase-IN-1 | ||
Glucocerebrosidase-IN-1 (compound 11a) is a potent and selective GCase (glucocerebrosidase) inhibitor, with an IC 50 of 29.3 μM and a K i of 18.5 μM. Due to GCase involvement in pathological disorders consequent to enzym... | |||
T78671 | Glucocerebrosidase-IN-1 hydrochloride | Glucosidase | |
Glucocerebrosidase-IN-1 (compound 11a) hydrochloride is a potent, selective GCase (glucocerebrosidase) inhibitor with IC50 and Ki values of 29.3 μM and 18.5 μM, respectively. It is utilized in the research of Gaucher dis... | |||
T8986 | ML198 | Glucokinase | |
ML198 is a novel activator and non-inhibitory chaperone of glucocerebrosidase. ML198 serves as a starting point to develop a novel approach towards small molecule treatment for patients suffering from Gaucher disease. | |||
T0920 | Ambroxol | Ambroxolum,NA-872 | P450 , Autophagy |
Ambroxol (NA-872) is a secretolytic agent used in the treatment of respiratory diseases associated with viscid or excessive mucus. It is the active ingredient of Mucosolvan, Lasolvan or Mucoangin. The substance is a muco... | |||
T6234 | Ambroxol hydrochloride | Mucosolvan,Mucoangin,Ambroxol HCl | Sodium Channel , Autophagy |
Ambroxol hydrochloride (Mucosolvan) is a metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride. | |||
T40544 | NCGC00092410 | ML008 | Glucosidase |
NCGC00092410 (ML008) is a glucocerebrosidase (GC) inhibitor with IC50 value of 31 nM. It can be used for the study of Gaucher disease caused by mutation of glucocerebrase gene. | |||
T8989 | NCGC 607 | NCGC607 | Others |
NCGC 607 is a a noninhibitory chaperone of glucocerebrosidase (GCase). | |||
T60048 | WAY-640509 | Glucokinase | |
WAY-640509 is a glucocerebrosidase inhibitor. | |||
T4280 | Gcase activator 1 | LTI-291,LTI 291,LTI291 | Glucosidase |
Gcase activator 1 (LTI-291) is a glucocerebrosidase (Gcase) activator. | |||
T8990 | ML266 | Glucokinase | |
ML266, a glucocerebrosidase (GCase) chaperone with an IC50 of 2.5 µM, facilitates the transport of the mutant protein to the lysosome, thereby restoring GCase activity without inhibiting the enzyme's function. This compo... | |||
T39518 | PFB-FDGlu | Others | |
PFB-FDGlu is a lysosomal Glucocerebrosidase (GCase) substrate with cell-permeable specificity that is cleaved to produce fluorescein.PFB-FDGlu is often used in conjunction with a flow cytometer to measure GCase activity ... | |||
T37440 | C2 Adamantanyl Galactosylceramide (d18:1/2:0) | ||
C2 Adamantanyl Galactosylceramide (d18:1/2:0) (AdaGalCer) is a bioactive sphingolipid. It reduces globotriaosylceramide 3 synthesis from exogenous lactosylceramide in microsomes. AdaGalCer stimulates recombinant glucocer... | |||
T80994 | Therapeutic agent-1 | ||
Therapeutic Agent-1, a heteroaryl compound, serves as an enzyme replacement therapy to enhance glucocerebrosidase activity in the treatment of Gaucher disease [1]. | |||
T78493 | Glucosylsphingosine | Lyso-Gb1,Glucopsychosine | |
Glucosylsphingosine (lyso-Gb1), a deacylated glucosylceramide derivative metabolized by glucocerebrosidase, serves as a promising, reliable, and specific biomarker for Gaucher disease monitoring [1]. | |||
T37928 | 13C6 Glucosylsphingosine (d18:1) | ||
13C6 Glucosylsphingosine (d18:1) is an isotopically enriched form of 1-β-D-glucosylsphingosine (d18:1) that is intended for use as an internal standard for the quantification of 1-β-D-glucosylsphingosine by GC- or LC-MS.... | |||
T38213 | 1-β-D-Glucosylsphingadienine (d18:2 (4E,8E)) | 1-β-D-Glucosylsphingadienine (d18:2 (4E,8E)) | |
1-β-D-Glucosylsphingadienine is a glucosylsphingosine, which are deacetylated lysolipid derivatives of glucosylcerebrosides . They are formed when sphingosines undergo glucosidation by UDP-glucose. Glucosylsphingosines c... |